(Q37820092)

23 August 2017

1 reference

title

Oxidative stress in early diabetic nephropathy: fueling the fire (English)

1 reference

23 August 2017

0 references

1 reference

Dhruv K Singh

1

1 reference

23 August 2017

Peter Winocour

series ordinal

2

1 reference

23 August 2017

Ken Farrington

series ordinal

3

1 reference

23 August 2017

publication date

14 December 2010

1 reference

Nature Reviews Endocrinology

23 August 2017

published in

1 reference

23 August 2017

volume

7

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

176-184

1 reference

Cardiac disease in diabetic end-stage renal disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

NADPH oxidases in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

The Nox family of NAD(P)H oxidases: host defense and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Subcellular localization of Nox4 and regulation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Advanced glycosylation end products in diabetic renal and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Renal tubular proteinuria and microalbuminuria in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Can we model nitric oxide biotransport? A survey of mathematical models for a simple diatomic molecule with surprisingly complex biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

A novel superoxide-producing NAD(P)H oxidase in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Cross-talk between nitric oxide and superoxide determines ceramide formation and apoptosis in glomerular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Erk 1,2 phosphorylates p27(Kip1): Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Extracellular matrix metabolism in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Hydrogen peroxide is a novel inducer of connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Stressed-out podocytes in diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Hypoxic induction of Ctgf is directly mediated by Hif-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

NO restores HIF-1alpha hydroxylation during hypoxia: role of reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

The role of reactive oxygen species in apoptosis of the diabetic kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Reduction of renal superoxide dismutase in progressive diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Cellular sites of H2O2-induced damage and their protection by nitroxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Heme oxygenase and the cardiovascular-renal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Effects of statins on endothelium and signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Ascorbic acid, glycation, glycohemoglobin and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Ruboxistaurin: PKC-beta inhibition for complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Pirfenidone is renoprotective in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Moderate exercise with a dietary vitamin C and e combination protects against streptozotocin-induced oxidative damage to the kidney and lens in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Endothelium-dependent contractions and endothelial dysfunction in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

NOX enzymes and the biology of reactive oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Activation of the JAK-STAT pathway by reactive oxygen species.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Diabetic nephropathy and proximal tubule ROS: challenging our glomerulocentricity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Endothelial nitric oxide synthase uncoupling: Is it a physiological mechanism of endothelium-dependent relaxation in cerebral artery?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.212

Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide

31 March 2020

1 reference

12 December 2020

Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney

1 reference

12 December 2020

The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes

1 reference

12 December 2020

Differential expression of basement membrane collagen chains in diabetic nephropathy

1 reference

12 December 2020

Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy

1 reference

12 December 2020

Molecular mechanisms for vascular injury in the metabolic syndrome

1 reference

12 December 2020

Reactive oxygen species and antioxidants in signal transduction and gene expression

1 reference

12 December 2020

Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells

1 reference

12 December 2020

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

12 December 2020

Role of oxidative stress in diabetic kidney disease.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2010.212

1 reference

23 August 2017

1 reference